In this YouTube short, a primary‑care physician who runs a biohacking‑focused channel warns viewers about three notable side effects associated with retatrutide (a GLP‑1 receptor agonist). First, the doctor explains allodynia—skin pain from light touch—arising from retatrutide’s modulation of glucagon receptors in sensory neurons, and notes that most patients manage it by temporarily lowering the dose. Second, the video highlights that rapid weight loss, whether from retatrutide or other means, raises the risk of gallstones, especially presenting as right‑upper‑quadrant pain after fatty meals, which requires medical evaluation. Third, the physician mentions the theoretical risk of pancreatitis with GLP‑1 drugs, advising immediate medical attention for severe, persistent upper abdominal pain radiating to the back. The doctor emphasizes that these two latter side effects lack simple fixes, urging viewers to seek professional guidance and not rely on Reddit or other unverified sources. The short concludes with a brief personal note about the creator’s interest in metabolic optimization and a call to like and subscribe.
